tiprankstipranks
Ingevity (NGVT)
NYSE:NGVT
US Market
Want to see NGVT full AI Analyst Report?

Ingevity (NGVT) Earnings Dates, Call Summary & Reports

223 Followers

Earnings Data

Report Date
Aug 05, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
1.35
Last Year’s EPS
1.39
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 06, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a generally positive operational performance and strategic progress: revenue growth, strong Performance Materials results, disciplined capital allocation with accelerated share repurchases, and continued portfolio simplification. However, the quarter also featured notable headwinds — negative Q1 free cash flow due to inventory builds, GAAP special charges and sizable upcoming litigation payments, a weak Road Markings/pavement performance, and margin pressure in APT. On balance the operational wins, reaffirmed guidance, and active capital deployment outweighed the near-term cash and segment-specific challenges.
Company Guidance
Ingevity reaffirmed its 2026 guidance, calling for adjusted EPS of $4.70–$5.20, sales of $1.05–$1.15 billion, adjusted EBITDA of $370–$395 million and free cash flow of $215–$245 million (which excludes roughly $113 million of pretax BASF litigation payments expected in Q2); the outlook excludes Road Markings after its April 15 sale and is expected to lift Performance Chemicals margin to the high teens while Performance Materials full‑year EBITDA margins are expected around the mid‑50s. Management reiterated a target net leverage of 2.0–2.5x in 2026, committed to $300 million of share repurchases through 2027 (having repurchased ~$52 million—~775,000 shares—in Q1, ~ $15 million already in Q2, and with ~ $246 million remaining authorization at quarter end), expects to capture ~$15 million of run‑rate indirect cost savings from the Industrial Specialties divestiture by year‑end, and is working to complete an APT sale before the end of the year.
Disciplined Capital Allocation and Accelerated Buybacks
Company repurchased approximately $52 million of shares (~775,000 shares) in Q1 and had ~ $246 million remaining authorization at quarter end. Management reiterated a plan to complete $300 million of share repurchases through 2027 and has already repurchased nearly $15 million in Q2.
Portfolio Simplification and Non-Core Divestitures
Completed the sale of the Ozark Materials Road Markings product line for roughly $65 million (April 15) and previously divested the North Charleston CTO refinery and majority of Industrial Specialties for ~ $93 million net proceeds. The APT sale process is progressing with active buyer interest.
Reaffirmed 2026 Guidance and Cash Flow Targeting
Management reaffirmed full-year guidance: adjusted EPS $4.70–$5.20, sales $1.05–$1.15 billion, adjusted EBITDA $370–$395 million, and expected free cash flow of $215–$245 million (note: excludes certain litigation-related payments). Target net leverage remains 2.0–2.5x.
Revenue Growth and Solid Profitability
Total sales grew 4% year-over-year to $258 million. Adjusted gross profit increased 4% to $132 million with a gross margin of 51%. Adjusted EBITDA was $92 million and adjusted diluted EPS improved 14% to $1.15, supported by lower interest expense and share repurchases.
Outperformance in Performance Materials
Performance Materials sales of $155 million rose 6% YoY. Segment EBITDA increased 10% to $92 million and margin expanded to 59% (from 57%), driven by pricing, higher volumes and a favorable mix from a shift to hybrids. Management expects any inventory-driven benefit (~$5–6 million) to reverse in Q2 with full-year margins returning to the mid-50s.

Ingevity (NGVT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NGVT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 05, 2026
2026 (Q2)
1.35 / -
1.39
May 06, 2026
2026 (Q1)
0.83 / 1.15
0.9916.16% (+0.16)
Feb 25, 2026
2025 (Q4)
0.67 / 0.63
0.95-33.68% (-0.32)
Nov 05, 2025
2025 (Q3)
1.37 / 1.52
1.138.18% (+0.42)
Aug 05, 2025
2025 (Q2)
1.16 / 1.39
1.0137.62% (+0.38)
May 05, 2025
2025 (Q1)
0.74 / 0.99
0.5290.38% (+0.47)
Feb 18, 2025
2024 (Q4)
0.31 / 0.95
0.21352.38% (+0.74)
Oct 29, 2024
2024 (Q3)
0.88 / 1.10
1.21-9.09% (-0.11)
Jul 31, 2024
2024 (Q2)
1.05 / 1.01
1.41-28.37% (-0.40)
May 01, 2024
2024 (Q1)
0.34 / 0.52
1.09-52.29% (-0.57)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NGVT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2026
$77.87$74.07-4.88%
Feb 25, 2026
$69.60$70.52+1.32%
Nov 05, 2025
$54.46$46.20-15.17%
Aug 05, 2025
$49.56$48.89-1.35%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ingevity (NGVT) report earnings?
Ingevity (NGVT) is schdueled to report earning on Aug 05, 2026, After Close (Confirmed).
    What is Ingevity (NGVT) earnings time?
    Ingevity (NGVT) earnings time is at Aug 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NGVT EPS forecast?
          NGVT EPS forecast for the fiscal quarter 2026 (Q2) is 1.35.